Apomorphine

Verify with FDA CVM →

131 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
131
Total Reports
11
Deaths Reported
840.0%
Death Rate

Active Ingredients

Apomorphine

Administration Routes

UnknownIntravenousSubconjunctivalOphthalmicIntramuscularIntraocularOtherSubcutaneousParenteralUrethral

Species Affected

Dog 127
Cat 4

Most Affected Breeds

Retriever - Labrador 18
Dog (unknown) 8
Crossbred Canine/dog 8
Retriever - Golden 8
Beagle 6
Terrier - Yorkshire 4
Mixed (Dog) 3
Domestic Shorthair 3
Shih Tzu 3
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 3

Most Reported Reactions

Vomiting 54
Accidental exposure 33
Overdose 28
Seizure NOS 14
Lethargy (see also Central nervous system depression in 'Neurological') 13
Emesis 13
Tremor 8
Diarrhoea 7
Other abnormal test result NOS 7
Anorexia 7
Elevated blood urea nitrogen (BUN) 7
Death 6

Outcome Breakdown

Recovered/Normal
51 (38.9%)
Ongoing
42 (32.1%)
Outcome Unknown
27 (20.6%)
Died
6 (4.6%)
Euthanized
5 (3.8%)

Data Summary

Metric Value
Total adverse event reports 131
Reports involving death 11
Case-fatality rate (reported events) 840.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Apomorphine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 131 adverse event reports referencing Apomorphine, including 11 reports in which the animal died — a 840.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Apomorphine. Reported administration routes include Unknown, Intravenous, Subconjunctival, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Apomorphine reports are Dog (127 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (18), Dog (unknown) (8), Crossbred Canine/dog (8) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Apomorphine are Vomiting (54), Accidental exposure (33), Overdose (28), Seizure NOS (14). Of the 131 reports with a coded outcome, Recovered/Normal is the leading category at 38.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Apomorphine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial